PKI 115.4 (+0.44%)
US7140461093Medical Diagnostics & ResearchDiagnostics & Research

PerkinElmer (PKI) Competitor Comparison

We are evaluating the key criteria listed to compare PerkinElmer (PKI) against its competitors in the Diagnostics & Research industry.

Performance 5 years - PKI ranking 11 / 58

These are the competitors of PerkinElmer in the industry Diagnostics & Research ranked by performance 5 years
1. Lantheus Holdings LNTH
644.45
2. RadNet RDNT
331.74
3. Natera NTRA
328.6
4. Medpace Holdings MEDP
248.56
5. Meridian Bioscience VIVO
118.46
6. Laboratory Corp of America Holdings LH
77.28
7. Quest Diagnostics DGX
76.13
8. Waters WAT
63.18
9. DarioHealth DRIO
61.4
10. IDEXX Laboratories IDXX
53.38
11. PerkinElmer PKI
48.44
12. Mettler-Toledo MTD
41.9
13. Anixa Biosciences ANIX
36
14. Danaher DHR
34.02
15. Agilent Technologies A
27.96
16. Thermo Fisher Scientific TMO
27.91
17. Twist Bioscience TWST
20.18
18. Ortho Clinical Diagnostics Holdings OCDX
13.74
19. IQVIA Holdings IQV
12.4
20. Heska HSKA
12.14
21. Fulgent Genetics FLGT
8.64
22. Co-Diagnostics CODX
6.45
23. Qiagen QGEN
1.6
24. DexCom DXCM
-11.77
25. Icon ICLR
-12.7
26. Syneos Health SYNH
-16.98
27. CareDx CDNA
-24.15
28. Charles River Laboratories CRL
-26.34
29. Olink Holding OLK
-26.82
30. Guardant Health GH
-37.07
31. Exact Sciences EXAS
-43.32
32. Bioventus BVS
-48.21
33. Myriad Genetics MYGN
-49.44
34. Precipio PRPO
-55.52
35. Psychemedics PMD
-58.08
36. Sotera Health SHC
-61.19
37. Inotiv NOTV
-61.5
38. Pacific Biosciences of California PACB
-61.51
39. Personalis PSNL
-64.52
40. Enzo Biochem ENZ
-65.26
41. NeoGenomics NEO
-67.57
42. Exagen XGN
-68.25
43. Illumina ILMN
-76.36
44. Sera Prognostics SERA
-77.35
45. National Research NRC
-79.12
46. Trinity Biotech TRIB
-81.02
47. MaxCyte MXCT
-84.64
48. Global Cord Blood CO
-86.47
49. Interpace Biosciences IDXG
-86.51
50. MDxHealth MDXH
-86.83
51. Neogen NEOG
-86.86
52. bioAffinity Technologies BIAF
-88.45
53. Neuronetics STIM
-92.42
54. Biodesix BDSX
-92.64
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-96.65

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.